Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP-786 in agitation in Alzheimer's dementia
NCT02446132Phase 3Terminated
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2015
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of deudextromethorphan in Alzheimer's disease (AD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Nov 2015; status: terminated.
02
Drugs
deudextromethorphan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02446132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446132.